/ The tracker
A tirzepatide tracker that keeps the whole record.
Tirzepatide acts at both the GIP and GLP-1 receptors and runs weekly. OptimusPep tracks the schedule, the sites and what is left in the vial, and pairs it with the nutrition and training context that decides how much lean mass comes along for the ride.
Coming soon
Tracking and educational only, not medical advice.
Weekly schedule, visible
Next dose and adherence in view, so a missed week is a fact rather than a feeling.
Draw arithmetic included
Your vial strength and water volume become a concentration and a mark to draw to.
Sourced reference
Half-life, handling and approval standing, each opening the public record behind it.
The reference entry
Tirzepatide
A dual GIP and GLP-1 receptor agonist with a fatty-diacid modification for albumin binding, studied for glycemic control in type 2 diabetes and for weight management. Its half-life supports once-weekly administration.
Half-life · ~5 days (~120 h), subcutaneous
Read the full entry and open its sources →OptimusPep is a tracking, educational and record-keeping tool for values you enter yourself. It does not provide medical advice, diagnosis, treatment or dosing recommendations, and does not sell or source any compound.